Spatiotemporal Synergism in Osteomyelitis Treatment with Photoactivated Core–Shell Zinc Oxide/Silver Sulfide Heterogeneous Nanoparticles

Osteomyelitis is primarily caused by bacterial infections, and treatment requires precise sequential therapy, including antibacterial therapy in the early stages and bone defect reconstruction in later stages. We aimed to synthesize core–shell-structured zinc oxide/silver sulfide heterogeneous nanoparticles (ZnO/Ag 2 S NPs) using wet chemical methods. Using density functional theory and ultraviolet photoelectron spectroscopy, we showed that the optimized band structure endowed ZnO/Ag 2 S NPs with photodynamic properties under near-infrared (NIR) irradiation. Moreover, ZnO/Ag 2 S NPs exhibited a distinguished and stable photothermal performance within the same wavelength range. With single-wavelength irradiation, ZnO/Ag 2 S NPs achieved a bifunctional antibacterial effect during the acute stage of osteomyelitis. Antibacterial action was confirmed through colony-forming unit (CFU) counting assays, scanning electronic microscopy (SEM) observations, live–dead staining, growth curves, and quantitative real-time polymerase chain reaction (qPCR) assays. The Ag 2 S coating on the NPs realized the sustained release of zinc ions, thereby controlling the zinc ion concentration. Alkaline phosphatase (ALP) staining, alizarin red S (ARS) staining, and qPCR assays confirmed that the ZnO/Ag 2 S NPs exhibited good osteogenic effects in vitro . These effects were verified in an in vivo mouse femur model during chronic stages using micro-computed tomography (micro-CT) and histological analysis. This study provides a novel biocompatible core–shell nanomaterial for the two-phase treatment of osteomyelitis, contributing to versatile nanotherapies for infections and inflammation.